These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 19581599

  • 1. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus.
    Faber M, Li J, Kean RB, Hooper DC, Alugupalli KR, Dietzschold B.
    Proc Natl Acad Sci U S A; 2009 Jul 07; 106(27):11300-5. PubMed ID: 19581599
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.
    Faber M, Dietzschold B, Li J.
    Zoonoses Public Health; 2009 Aug 07; 56(6-7):262-9. PubMed ID: 19486317
    [Abstract] [Full Text] [Related]

  • 3. Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.
    Li J, Ertel A, Portocarrero C, Barkhouse DA, Dietzschold B, Hooper DC, Faber M.
    J Virol; 2012 Mar 07; 86(6):3200-10. PubMed ID: 22238315
    [Abstract] [Full Text] [Related]

  • 4. Efficiency of live attenuated and inactivated rabies viruses in prophylactic and post exposure vaccination against the street virus strain.
    Huang F, Ahmad W, Duan M, Liu Z, Guan Z, Zhang M, Qiao B, Li Y, Song Y, Song Y, Chen Y, Amjad Ali M.
    Acta Virol; 2015 Jun 07; 59(2):117-24. PubMed ID: 26104328
    [Abstract] [Full Text] [Related]

  • 5. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B.
    Virology; 2015 Jun 07; 356(1-2):147-54. PubMed ID: 16938327
    [Abstract] [Full Text] [Related]

  • 6. Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies.
    Wu X, Franka R, Henderson H, Rupprecht CE.
    Vaccine; 2011 Jun 06; 29(25):4195-201. PubMed ID: 21514343
    [Abstract] [Full Text] [Related]

  • 7. Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ.
    Barkhouse DA, Faber M, Hooper DC.
    Virology; 2015 Jan 01; 474():174-80. PubMed ID: 25463615
    [Abstract] [Full Text] [Related]

  • 8. Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection.
    Dorfmeier CL, Lytle AG, Dunkel AL, Gatt A, McGettigan JP.
    J Virol; 2012 Nov 01; 86(21):11533-40. PubMed ID: 22896601
    [Abstract] [Full Text] [Related]

  • 9. Inadequate antibody response to rabies vaccine in immunocompromised patient.
    Kopel E, Oren G, Sidi Y, David D.
    Emerg Infect Dis; 2012 Sep 01; 18(9):1493-5. PubMed ID: 22932226
    [Abstract] [Full Text] [Related]

  • 10. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
    Franka R, Wu X, Jackson FR, Velasco-Villa A, Palmer DP, Henderson H, Hayat W, Green DB, Blanton JD, Greenberg L, Rupprecht CE.
    Vaccine; 2009 Nov 27; 27(51):7149-55. PubMed ID: 19925945
    [Abstract] [Full Text] [Related]

  • 11. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J, Tan GS, Papaneri AB, Dietzschold B, Schnell MJ, McGettigan JP.
    Vaccine; 2008 Nov 25; 26(50):6405-14. PubMed ID: 18804506
    [Abstract] [Full Text] [Related]

  • 12. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system.
    Hooper DC, Phares TW, Fabis MJ, Roy A.
    PLoS Negl Trop Dis; 2009 Oct 06; 3(10):e535. PubMed ID: 19806203
    [Abstract] [Full Text] [Related]

  • 13. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Giel-Moloney M, Rumyantsev AA, David F, Figueiredo M, Feilmeier B, Mebatsion T, Parrington M, Kleanthous H, Pugachev KV.
    Vaccine; 2017 Dec 14; 35(49 Pt B):6898-6904. PubMed ID: 28899628
    [Abstract] [Full Text] [Related]

  • 14. Postexposure rabies prophylaxis in immunosuppressed patients.
    Gibbons RV, Rupprecht CE.
    JAMA; 2001 Mar 28; 285(12):1574-5. PubMed ID: 11268256
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL, Esposito JJ, Ewalt LC.
    Vaccine; 2004 Sep 03; 22(25-26):3329-33. PubMed ID: 15308356
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.